Index trend and stocks in action January 03, 2020

Index trend and stocks in action January 03, 2020

Karan Dsij
/ Categories: Trending

The bulls scored a century on Thursday and recorded a closing high. At present, it is within a striking distance from the all-time high level of 12,294. The price action of the day formed a sizable bullish candle.

After registering an all-time high level of 12,294, the index entered into a corrective and sideways mode. It has been moving in a range for the past eight trading sessions and if we compare the current range with the earlier one, the former apperars smaller than the latter, as it is a range of around 175 points. In this range move, we have observed a divergent signal in major indicators. As we discussed earlier, the divergences in all timeframes are not a good sign at this juncture. Nifty is moving up but the trend strength looks weaker. The momentum is waning. Within this range move, the leading indicator RSI formed lower highs. The ADX is moving down. The MACD histogram is still around zero with negative momentum. The indifferent behavior of the price is surprising the fundamental analysts as well.

Nifty is making fourth attempt to cross the level of 12,300 and in any case, the flat base breakout or closing above 12,300 means there would be another room for 100-175 points on the upside for the index. While a move below the 12,100 level would be the first sign of weakness. At this higher valuation zone on the backdrop of weaker economic data points, there is an element of doubt in the mind of traders. Let us watch as to where this less-trustworthy rally takes us. As of now, be with positive bias as long as it is trading above 12,110.

Natco Pharma: Natco Pharma is pleased to announce its submission of an abbreviated new drug application (ANDA), containing a paragraph IV certification with the U.S. Food and Drug Administration (FDA) for the generic version of Lonsurf® (Trifluridine/ Tipiracil) tablets (15mg/6.14mg and 20mg/8.19mg).

JSW Energy: The company has entered into an agreement with Jai Prakash Power Ventures (JVPL) on January 02, 2020, to re-structure the principal outstanding amount of Rs 751.77 crore, owed by JPVL to the  company.

FDC: The company has received GMP certificate and it continues with its approved status from the UK MHRA for two of its oral solid dosage.

TCS: TCS has been named a leader and star performer in Life & Pensions Insurance BPO services by Everest Group.

RITES: RITES has secured a major work of project management consultancy from the Government of Bangladesh, amounting to Rs 99.94 crore. RITES is a leading partner in the JV arrangement and will receive Rs 77.57 crore out of the total consultancy fee of Rs 99.94 crore.

Previous Article Uncharted territory to be the theme of the day
Next Article NMDC reports 7 per cent rise in Lump Ore prices for January 2020
Rate this article:
5.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR